Curtis C Harris

发表

tsRNA signatures in cancer

Paolo Visca, Giovanni Nigita, Dario Veneziano, 2017, Proceedings of the National Academy of Sciences.

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study.

Zhifu Sun, Feng Chen, Mariza de Andrade, 2010, The Lancet. Oncology.

Evolutionary conservation and somatic mutation hotspot maps of p53: correlation with p53 protein structural and functional features

Wojciech Makalowski, M. Boguski, C. Harris, 1999, Oncogene.

Female chromosome X mosaicism is age-related and preferentially affects the inactivated X chromosome

William Wheeler, Nan Hu, Peter Kraft, 2016, Nature Communications.

Clinical outcomes and correlates of TP53 mutations and cancer.

C. Harris, A. Robles, Curtis C Harris, 2010, Cold Spring Harbor perspectives in biology.

Nutlin-3a activates p53 to both down-regulate inhibitor of growth 2 and up-regulate mir-34a, mir-34b, and mir-34c expression, and induce senescence.

Izumi Horikawa, Jun Yokota, Seiichi Takenoshita, 2008, Cancer research.

Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture.

Melinda C Aldrich, Gaurav Bhatia, David Reich, 2014, American journal of human genetics.

Polymorphisms in XPD and TP53 and mutation in human lung cancer.

Leah E Mechanic, Leah E. Mechanic, E. Bowman, 2004, Carcinogenesis.

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

Koji Tsuta, Shun-ichi Watanabe, Yoko Shimada, 2014, Clinical Cancer Research.

MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

George A Calin, Jane J. Sohn, Krista A. Zanetti, 2008, JAMA.

Noninvasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer.

Emmanuel Hatzakis, Ewy A Mathé, E. Bowman, 2014, Cancer research.

Increased miR-708 Expression in NSCLC and Its Association with Poor Survival in Lung Adenocarcinoma from Never Smokers

Zhifu Sun, Ping Yang, Jin Jen, 2012, Clinical Cancer Research.

The p53 tumor suppressor network is a key responder to microenvironmental components of chronic inflammatory stress.

John N Weinstein, Frank Staib, X. Wang, 2005, Cancer research.

Urinary Metabolite Risk Biomarkers of Lung Cancer: A Prospective Cohort Study

William J Blot, Ewy A Mathé, H. Munro, 2016, Cancer Epidemiology, Biomarkers & Prevention.

BLM helicase facilitates Mus81 endonuclease activity in human cells.

N. Yanaihara, C. Harris, S. Linke, 2005, Cancer research.

Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and women.

Leah E Mechanic, Michele R Forman, Leah E. Mechanic, 2010, Carcinogenesis.

p53-repressed miRNAs are involved with E2F in a feed-forward loop promoting proliferation

Shalom Madar, Ido Goldstein, Varda Rotter, 2008, Molecular systems biology.

The Expression of Four Genes as a Prognostic Classifier for Stage I Lung Adenocarcinoma in 12 Independent Cohorts

Jun Yokota, Takashi Kohno, Seiichi Takenoshita, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer.

Jun Yokota, Takashi Kohno, E. Bowman, 2015, Cancer research.

Characterization of large structural genetic mosaicism in human autosomes.

William Wheeler, Nan Hu, Peter Kraft, 2015, American journal of human genetics.

Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer.

Vassilis G Gorgoulis, Varda Rotter, Noam Harpaz, 2013, Cancer cell.

Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case‐control study

Leah E. Mechanic, Ourania Kosti, E. Bowman, 2010, International journal of cancer.

Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer

Julie Goodman, Meredith Yeager, Krista A. Zanetti, 2014, International journal of cancer.

Detectable clonal mosaicism and its relationship to aging and cancer

William Wheeler, Nan Hu, Peter Kraft, 2012, Nature Genetics.

Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33.

William Wheeler, Hideo Tanaka, Jianxin Shi, 2014, Human molecular genetics.

MicroRNA Involvement in Human Cancers.

N. Yanaihara, C. Harris, Curtis C Harris, 2013, Clinical chemistry.

KIF5B-RET fusions in lung adenocarcinoma

Yasushi Totoki, Koji Tsuta, Shun-ichi Watanabe, 2012, Nature Medicine.

Functional diversity of human protection of telomeres 1 isoforms in telomere protection and cellular senescence.

Izumi Horikawa, Antti Kokko, Päivi Laiho, 2007, Cancer research.

The Association of MicroRNA Expression with Prognosis and Progression in Early-Stage, Non–Small Cell Lung Adenocarcinoma: A Retrospective Analysis of Three Cohorts

Vidar Skaug, Motonobu Saito, Jun Yokota, 2011, Clinical Cancer Research.

Advances in chemical carcinogenesis: a historical review and prospective.

C. Harris, L. Loeb, Lawrence A Loeb, 2008, Cancer research.

Lung Cancer in Never Smokers: Molecular Profiles and Therapeutic Implications

William Pao, Erika Avila-Tang, J. Herman, 2009, Clinical Cancer Research.

p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.

Koh Miura, Jun Yokota, Ettore Appella, 2003, Cancer research.

Circulating microRNA expression profiles associated with systemic lupus erythematosus.

Mårten Segelmark, A. Schetter, C. Harris, 2013, Arthritis and rheumatism.

An Integrated Prognostic Classifier for Stage I Lung Adenocarcinoma Based on mRNA, microRNA, and DNA Methylation Biomarkers

David Petersen, Naoto Tsuchiya, Vidar Skaug, 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.